Patent ID: 7790397

Claim:
A method for making a short-term prognosis up to 30 days for a myocardial infarction patient by determining the level of three markers from a sample from the patient, wherein the three markers consist of N-terminal fragment of pro-BNP (NT-ProBNP) marker, at least one ischemic marker selected from the group consisting of troponin T and troponin I, and at least one inflammatory marker selected from the group consisting of C-reactive protein (CRP) and IL-6, comparing the pro-BNP (NT-ProBNP) level, the level of at least one of the ischemic markers and at least one of the inflammatory markers to a control, wherein an elevation of each the pro-BNP (NT-ProBNP), at least one of the ischemic markers, and at least one of the inflammatory markers as compared to the control indicates a less favorable prognosis.